Tuberculosis
📧 Sign up to get email alerts when something new happens for Tuberculosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-03-14Clinical Trial Update: Early Empiric Anti-Mycobacterium Tuberculosis Therapy for Sepsis in Sub-Saharan Africa [Phase 3]
A Phase 3 clinical trial update for early empiric anti-tuberculosis therapy in sepsis patients in Sub-Saharan Africa is reported as status u…
-
CLINICAL_TRIALS trial_result · 2023-02-27Clinical Trial Update: MTBVAC Study in Adults With and Without Latent Tuberculosis Infection in South Africa [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating MTBVAC in adults with and without latent TB infection in South Africa has completed.
-
CLINICAL_TRIALS trial_result · 2023-02-22Clinical Trial Update: Efficacy of N-acetylcysteine to Prevent Anti-tuberculosis Drug-induced Liver Injury: A Randomized Controlled Trial [Phase 2, Phase 3]
A randomized controlled trial evaluating N-acetylcysteine to prevent anti-tuberculosis drug-induced liver injury in tuberculosis patients.
-
CLINICAL_TRIALS trial_result · 2023-02-17Clinical Trial Update: High-Dose Isoniazid Among Adult Patients With Different Genetic Variants of INH-Resistant Tuberculosis (TB) [Phase 2]
Phase 2 trial evaluating high-dose isoniazid in adults with INH-resistant tuberculosis across different genetic variants; study completed wi…
-
FDA approval · 2022-12-21FDA Approved: PRETOMANID — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for Pretomanid, submitted by Viatris Specialty LLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-12-02Clinical Trial Update: Comparative Effectiveness/Implementation of TB Case Finding in Rural South Africa [NA]
Completed clinical trial evaluating comparative effectiveness and implementation of tuberculosis case finding in rural South Africa; results…
-
CLINICAL_TRIALS trial_result · 2022-11-30Clinical Trial Update: Study of the Safety and Efficacy of the Subunit Recombinant Tuberculosis Vaccine GamTBvac [Phase 3]
Phase 3 trial update for the subunit recombinant Tuberculosis vaccine GamTBvac evaluating safety and efficacy.
-
CLINICAL_TRIALS trial_result · 2022-11-02Clinical Trial Update: A Study of GC3107(BCG Vaccine) in Healthy Infants [Phase 3]
Phase 3 trial of GC3107 (BCG vaccine) in healthy infants completed.
-
CLINICAL_TRIALS trial_result · 2022-08-10Clinical Trial Update: A Exploratory Study of Vγ2Vδ2 T Lymphocyte-based Immunotherapy for MDR-TB [Phase 4]
A Phase 4 exploratory study evaluating γδ T cell-based immunotherapy for multidrug-resistant tuberculosis is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2022-08-05Clinical Trial Update: EMaBS TB Vaccine Study [Phase 1, Phase 2]
Phase 1/2 trial update for the EMaBS TB vaccine, reporting safety and immunogenicity data.
-
CLINICAL_TRIALS trial_result · 2022-05-24Clinical Trial Update: FS-1 Drug for Treatment of Multiple Drug-resistant Tuberculosis [Phase 3]
Phase 3 trial update for FS-1 in treating multi-drug resistant tuberculosis has completed.
-
CLINICAL_TRIALS trial_result · 2022-05-17Clinical Trial Update: Oral Vitamin D and Toll Like Receptor in Spondylitis Tuberculosis [Phase 2, Phase 3]
A trial update on an oral vitamin D and Toll-like receptor approach for spondylitis tuberculosis in Phase 2 and Phase 3 is reported with unk…
-
CLINICAL_TRIALS trial_result · 2022-03-02Clinical Trial Update: Sustainable East Africa Research in Community Health [NA]
Clinical trial update from a UCSF-sponsored study completed in 2022, focusing on HIV and tuberculosis with additional conditions listed in t…
-
FDA approval · 2022-01-29FDA Approved: RIFADIN IV — Supplemental Application (Sanofi-Aventis U.S. LLC)
FDA approved a supplemental application for the IV formulation Rifadin (rifampin) submitted by Sanofi-Aventis U.S. LLC.
-
CLINICAL_TRIALS trial_result · 2022-01-25Clinical Trial Update: Evaluating the EBA of Meropenem With Amoxicillin/Clavulanate and Pyrazinamide or Bedaquiline in Adults With PTB [Phase 2]
Phase 2 trial evaluating EBA of meropenem with amoxicillin/clavulanate and pyrazinamide or bedaquiline in adults with pulmonary tuberculosis…
-
CLINICAL_TRIALS trial_result · 2022-01-25Clinical Trial Update: Pharmacogenetics-guided Isoniazid Dosing in TB-HIV [Phase 2]
Phase 2 trial evaluating pharmacogenetics-guided isoniazid dosing in tuberculosis and HIV co-infected patients.
-
FDA approval · 2022-01-19FDA Approved: RIFAMPIN — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for Rifampin from Chartwell RX, LLC under an ANDA. This confirms approval of a generic Rifampin prod…
-
CLINICAL_TRIALS trial_result · 2021-12-20Clinical Trial Update: TB Innovation Project: A Pre- and Post- Implementation Assessment (TIPPI)
A completed clinical trial assessment evaluating TB innovation in pediatric tuberculosis care with posted results.
-
CLINICAL_TRIALS trial_result · 2021-12-01Clinical Trial Update: A Trial to Evaluate OPC 67683 in Participants With Pulmonary Sputum Culture-positive, Multidrug-resistant Tuberculosis (TB) [Phase 2]
Phase 2 trial update for OPC 67683 in pulmonary sputum culture-positive, multidrug-resistant tuberculosis (TB) has completed with results po…
-
CLINICAL_TRIALS trial_result · 2021-11-30Clinical Trial Update: Pharmacokinetic Study to Evaluate Double-Dose Levonorgestrel Emergency Contraception in Combination With Efavirenz-Based Antiretroviral Therapy or Rifampicin-Containing Anti-Tuberculosis Therapy [Phase 2]
Phase 2 pharmacokinetic study evaluating double-dose levonorgestrel emergency contraception with efavirenz-based ART or rifampicin-containin…
-
CLINICAL_TRIALS trial_result · 2021-11-11Clinical Trial Update: Safety and Pharmacokinetics (PK) in Multidrug-Resistant (MDR) Refractive Tuberculosis [Phase 2]
Phase 2 safety and pharmacokinetics study in multidrug-resistant refractive tuberculosis was terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2021-11-04Clinical Trial Update: The Treatment of Tuberculosis in HIV-Infected Patients [Phase 3]
Phase 3 trial update on treating tuberculosis in HIV-infected patients has completed.
-
CLINICAL_TRIALS trial_result · 2021-11-01Clinical Trial Update: A Trial to Evaluate Safety, Tolerability, and Efficacy of Orally Administered OPC-67683 [Phase 2]
Phase 2 trial evaluating safety, tolerability, and efficacy of orally administered OPC-67683 for tuberculosis, including multidrug-resistant…
-
CLINICAL_TRIALS trial_result · 2021-10-14Clinical Trial Update: Utilizing the Crosstalk Among Chicoric Acid, 13-Cis Retinoic Acid(Aerosolized), Minocycline and Vitamin D as a Potent Quadrate Therapy for Treating Patients With Multidrug-resistant TB and Patient With Both Multidrug-resistant TB and COVID-19 [Phase 2]
Phase 2 clinical trial investigating a combination therapy (chicoric acid, 13-cis retinoic acid aerosolized, minocycline, and vitamin D) for…
-
CLINICAL_TRIALS trial_result · 2021-09-29Clinical Trial Update: An Open-label RCT to Evaluate a New Treatment Regimen for Patients With Multi-drug Resistant Tuberculosis [Phase 2, Phase 3]
An open-label randomized trial evaluated a new treatment regimen for patients with multi-drug resistant tuberculosis, including phase 2 and …